Buy Apellis Pharma Stock | APLS Stock Price & Latest News | Public
APLS

Apellis Pharma

$0.00 (0.00%)Today

    About APLS

    Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The comp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.76
    -1.53
    -2.29
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.57

    Actual EPS
    Q3 2020

    Stats

    Market Cap$2,28B
    Volume18,84k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$45.04
    1 Year Low$16.85
    Open$29.32
    High$29.72
    Low$28.63

    Buy any stock with any amount of money.

    Download the App
    Download the app